Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development.
about
NFAM1, an immunoreceptor tyrosine-based activation motif-bearing molecule that regulates B cell development and signalingInterference with immunoglobulin (Ig)alpha immunoreceptor tyrosine-based activation motif (ITAM) phosphorylation modulates or blocks B cell development, depending on the availability of an Igbeta cytoplasmic tailQualitative regulation of B cell antigen receptor signaling by CD19: selective requirement for PI3-kinase activation, inositol-1,4,5-trisphosphate production and Ca2+ mobilizationThe CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation.Cytokine-driven loss of plasmacytoid dendritic cell function in chronic lymphocytic leukemiaImmunotherapy using unconjugated CD19 monoclonal antibodies in animal models for B lymphocyte malignancies and autoimmune disease.CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction.Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression.CD19 as a molecular target in CNS autoimmunity.Many paths lead to lupus.B lymphocyte-restricted expression of prion protein does not enable prion replication in prion protein knockout mice.Dendritic cells under investigation in autoimmune disease.B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse.A spontaneous deletion within the desmoglein 3 extracellular domain of mice results in hypomorphic protein expression, immunodeficiency, and a wasting disease phenotype.mTOR-Dependent and Independent Survival Signaling by PI3K in B Lymphocytes.Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning.The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cellsAntibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.Immunoglobulin recombinase gene activity is modulated reciprocally by interleukin 7 and CD19 in B cell progenitors.CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes.Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions.The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapyRegulatory B cell (B10 Cell) expansion during Listeria infection governs innate and cellular immune responses in mice.Antiviral protection and germinal center formation, but impaired B cell memory in the absence of CD19.B Cell in Autoimmune Diseases.Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesisB cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice.B lymphocytes differentially influence acute and chronic allograft rejection in miceChronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function.CD19, a response regulator of B lymphocytes, regulates wound healing through hyaluronan-induced TLR4 signaling.Transgenic expression of survivin compensates for OX40-deficiency in driving Th2 development and allergic inflammation.CD19: a promising B cell target for rheumatoid arthritis.Abnormal B lymphocyte activation and function in systemic sclerosis.Interleukin-10 production and T cell-suppressive capacity in B cell subsets from atherosclerotic apoE (-/-) mice.B lymphocytes in systemic sclerosis: Abnormalities and therapeutic targets.Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis.Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo.Alteration of B-cell antigen receptor signaling by CD19 co-ligation. A study with bispecific antibodies.Regulation of signalling through B-lymphocyte antigen receptors by cell-cell interaction molecules.Defective B cell ontogeny and immune response in human complement receptor 2 (CR2, CD21) transgenic mice is partially recovered in the absence of C3.
P2860
Q24293087-5D090E58-13B4-4E7A-B716-878F88A40038Q24675475-0ABC066B-A400-49F5-98B7-E883E97E315BQ28616251-DA490535-33CA-4E85-BC89-78CFAD5F1F52Q33707690-86352226-BCD4-46E6-91C7-FC1DA93F31F7Q33910990-76E4955B-8618-4917-85CB-F9066489D76CQ34085036-5354DE1F-1757-47B4-A793-4E395B48A7EFQ34577064-ACAA18B4-19F1-4BF6-8861-468367E9D8B5Q34831296-E583155D-3431-421B-B8C0-B7FA1053381FQ34976749-6AD2A27F-289C-4EA8-95C7-70724D32097BQ35045888-2BE062B7-894F-403C-8179-5E6C6BAAC75BQ35051960-7119ECB1-7F80-458C-9C21-8E8931699665Q35086727-83673AE7-D738-4864-B5DE-1958A73649CBQ35102984-833D3618-B330-4672-854A-AA6A98F3806BQ35143778-4B7513DF-592E-4801-BC13-065F774B9D3FQ35898010-BC22FE9F-AA88-4BCB-8104-81866BC83816Q35986612-DD5AE3F7-2926-4A00-BD09-5A9DFBF9C19FQ36165173-A612371A-4D02-4FD8-851A-CBFE69956439Q36228329-9A01E727-0551-49C1-A790-07CF87D3494CQ36365782-A1E921E9-D0AE-476E-8446-CA95576FFAB4Q36380952-8C5428F4-F6FE-4418-9299-8372EBAEA5B1Q36385029-B98CA984-40B0-46A2-8C59-DE85A384206AQ36402637-2E4E480C-906F-4451-B7B8-D879D9E753A4Q36553694-E874FCBD-C2A7-411B-95E7-2C9332B1565CQ36851746-4A236666-0A43-4351-9246-E97C2E6E3FE7Q36954468-BF8F0D90-2B18-4C5F-87A6-AE17EFBBA79CQ37031308-C0EF9B38-D392-4E3F-B289-8390C2A76B59Q37069120-CA64D555-7A65-44E0-88AE-D41F776B8DB4Q37072826-DA9DB218-5E0F-40F5-8F25-0A70E3FC3161Q37091230-BBA9BA31-17B0-47EC-A7B1-E9BACEE9FDE5Q37278463-DD1BFF50-B80B-4E0D-8A3C-D8E560848B8FQ37423123-DC5CD26D-A7C6-4F94-BC1D-179EFD520357Q37607076-B0C148D0-3CD8-4FA2-B5D2-27FD54D81D71Q38352418-D0DF70E5-7A8A-47CF-AE08-47C4D4ABDAB0Q38661039-B06CAD72-6148-4458-B10F-63822DED3964Q38701988-6E8B09CE-6430-46EC-B8DF-9088A9A94E80Q40110864-D1BBB2DA-F5CE-4E4C-923C-6BFB6A9A9C55Q40274082-FC514503-C802-4146-9102-D49DC4C5B321Q41168330-64CFB2A0-CA5D-40AC-AD3E-BCA896C7E8D0Q41332122-77917967-0852-4FB7-B379-7326B9C57766Q41910146-6D2AB521-9D50-432F-940E-48D87AA36622
P2860
Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Tissue-specific expression of ...... dent B-lymphocyte development.
@ast
Tissue-specific expression of ...... dent B-lymphocyte development.
@en
type
label
Tissue-specific expression of ...... dent B-lymphocyte development.
@ast
Tissue-specific expression of ...... dent B-lymphocyte development.
@en
prefLabel
Tissue-specific expression of ...... dent B-lymphocyte development.
@ast
Tissue-specific expression of ...... dent B-lymphocyte development.
@en
P2093
P2860
P356
P1476
Tissue-specific expression of ...... ndent B-lymphocyte development
@en
P2093
P2860
P304
P356
10.1128/MCB.14.6.3884
P407
P577
1994-06-01T00:00:00Z